Skip to main content
$5.07 +0.01 (+0.20%) At close · Jul 29
Market Cap
$517.75M
Shares
102.12M

Valneva SE Earnings Call Transcripts

Every quarterly earnings call for Valneva SE (VALN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Conference
Investor event
2026-11-16
Jefferies Global Healthcare Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-09-30
Valneva SE Q3 FY2025 Earnings Call
Positive tone IXCHIQ (chikungunya vaccine) U.S. suspension Lyme vaccine (VLA15) Phase III Shigella vaccine (S4V2)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Valneva SE Q2 FY2025 Earnings Call
Confident tone IXCHIQ (chikungunya vaccine) Lyme disease vaccine (VALOR / VLA15) Commercial product sales (IXIARO, DUKORAL, IXCHIQ)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Valneva SE Q1 FY2025 Earnings Call
Positive tone IXCHIQ label extensions, approvals and safety Quarterly financial performance and revenue growth Lyme disease Phase 3 VALOR program
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Valneva SE Q4 FY2024 Earnings Call
Positive tone IXCHIQ commercial ramp and competitive dynamics Lyme vaccine (VLA15) / Phase 3 VALOR Shigella program (S4V2)
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Valneva SE Q3 FY2024 Earnings Call
Positive tone IXCHIQ chikungunya vaccine launch IXIARO Japanese encephalitis vaccine and DOD Lyme disease vaccine (VLA15) program
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Valneva SE Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Valneva SE Q3 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Valneva SE Q2 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Valneva SE Q1 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Valneva SE Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Valneva SE Q3 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Valneva SE Q1 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Valneva SE Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–14 of 14 earnings calls
Key facts CIK 1836564 CUSIP 92025Y103 13F (30d) 4 filings 4 filers Visit website Investor relations